• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2016 Fiscal Year Final Research Report

Rational Development of Novel Hemagglutinin-based Influenza Virus Inhibitors

Research Project

  • PDF
Project/Area Number 26460158
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Drug development chemistry
Research InstitutionHoshi University

Principal Investigator

TSUBUKI Masayoshi  星薬科大学, 薬学部, 教授 (90163865)

Project Period (FY) 2014-04-01 – 2017-03-31
Keywordsインフルエンザ / ヘマグルチニン / ムメフラール / 不斉合成 / キラル分割 / 共結晶 / 構造活性相関
Outline of Final Research Achievements

Influenza A virus infects cells by the action of hemagglutinin (HA) and neuraminidase (NA). Mumefural (MF), isolated from Japanese apricot extract, is the first compound which shows inhibitory effect against both HA and NA activities of H1N1 influenza virus (A/Narita/1/2009). For the development of new anti-influenza drugs, total synthesis of (±)-MFwas achieved in 6 steps and 80 derivatives of MF were prepared. Their structure-activity relationship studies have revealed hydroxy dicarboxylic acid moiety was important for expression of the inhibition activity. The derivatives with bulky ester moiety improved the activity. A new compound 10 having adamantane framework on the ester part was synthesized, and its activity was 10 times more potent than that of MF. In addition, a 7-step asymmetric synthesis was developed, and both enantiomers were synthesized starting from (S) and (R)-malic acids. We have confirmed (S)-MF has an inhibitory activity 2 times stronger than that of (R)-MF.

Free Research Field

有機化学

URL: 

Published: 2018-03-22  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi